Histone H2B type F-S-like (H2B-F-S-like or LOC102724334)

The Histone H2B type F-S-like protein encoded by LOC102724334 (ENSG00000274559) is a putative member of the H2B family of core histone proteins that form essential components of the nucleosome core particle in eukaryotic chromatin[2]. Like other H2B proteins, it contributes to chromatin structure by assembling with H2A, H3, and H4 in the nucleosome, enabling the packaging of DNA within the nucleus and regulating accessibility through post-translational modifications[1][3]. Histone H2B and its variants are subject to extensive modifications (ubiquitination, acetylation, phosphorylation, methylation) that underpin epigenetic regulation of gene expression, DNA replication, and repair[1][3]. While major histone H2B proteins are well-characterized, many uncharacterized variants (such as H2B type F-S-like) lack functional studies, and there is no evidence this variant acts as an independent therapeutic target, disease biomarker, or is subject to specific pharmacologic modulation[2][3]. Limitations/Errors: This gene (ENSG00000274559/LOC102724334) is poorly characterized, and its designation as a "target" is likely incorrect. It is a putative histone variant gene with minimal evidence for a distinct or druggable biological role. Standardized nomenclature and curated databases (HGNC, UniProt) do not list it as a canonical histone or therapeutic target. Most relevant biomedical oversight consortia do not provide functional annotation or disease linkage for this locus. The entry appears to simply be a computationally predicted transcript or a low-confidence annotation. Summary: - This target is not a druggable receptor, enzyme, transporter, or typical therapeutic target. - It is minimally annotated and not recognized as an established molecular target in biology or medicine. - "Histone H2B type F-S-like" is a core histone family protein important to chromatin structure but not directly targetable by drugs nor used as a biomarker. - Use of this target for drug discovery or clinical intervention is not supported by current evidence[1][2][3].

Other names

Histone H2B family proteinENSG00000274559LOC102724334H2B type F-S-like

Not applicable. No known mechanism of action; not a typical pharmacological target.